- Home
- SVRA vs AI Comparison
SVRA vs AI Comparison
Compare SVRA & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | AI |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | 1181 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SVRA | AI |
|---|---|---|
| Price | $5.30 | $9.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $7.33 | ★ $15.25 |
| AVG Volume (30 Days) | 1.4M | ★ 6.8M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $389,056,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.27 |
| 52 Week Low | $1.89 | $7.72 |
| 52 Week High | $7.01 | $30.24 |
Technical Indicators
Market Signals| Indicator | SVRA | AI |
|---|---|---|
| Relative Strength Index (RSI) | 40.47 | 39.48 |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.06 | $14.34 |
| Average True Range (ATR) | 0.31 | 0.62 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 6.42 | 43.69 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.